There’s a new way to freeze your face. Currently dubbed RT002, the new type of neuromodulator — a wrinkle-busting class of treatments you might recognize by the brand names Botox, Xeomin, or Dysport — is making waves in the world of injectables. If approved by the Food and Drug Administration, it will be the first injection of its kind to last six months — and dermatologists are psyched.

“As a doctor, I love having more options and being able to choose the right products for the right patient in the right concentration and formulation,” Doris Day, a dermatologist in New York City and author of Beyond Beautiful, tells Allure. Developed by biotechnology company Revance, the daxibotulinumtoxinA injection just wrapped two clinical trials where it was shown to successfully treat moderate to severe glabellar lines (a.k.a. the furrow lines you get between your brows).